2025: A Year of Milestones in DS-AD
The medical advances made within the Down syndrome community over the past few decades have…
Shannon BergstresserJanuary 31, 2025
Your Support Matters – A look at LuMind IDSC’s 2024 impact
Over the past year, LuMind IDSC continued to make progress on our initiatives in research,…
A Season of Gratitude: Why My Family Supports LuMind IDSC
Thirty years ago, our family plans changed when our first child, Gwendolyn, was born with…
Shannon BergstresserNovember 8, 2024
Angie Del Gaudio Awarded Collin Lis Humanitarian Award
Angie Del Gaudio from Long Beach, CA has been selected as the 2024 Collin Lis…
Shannon BergstresserNovember 6, 2024
RAND report shows benefit of investment in future health outcomes for adults with Down syndrome
10/1/2024 | For immediate release | Contact: Kate O'Neill ([email protected]) Investment in Alzheimer’s Research Today…
Kate O’NeillSeptember 18, 2024
His Amazing Self: a brother’s reflection on Down syndrome-associated Alzheimer’s Disease
My brother, Rohan, was born 38 years ago in the city of Bangalore in India.…
Shannon BergstresserAugust 15, 2024
Pathways to Parity Program Approved for $250K PCORI Engagement Award
Project will empower advocates, enhance research for people at high risk of Alzheimer’s disease who…
Shannon BergstresserAugust 13, 2024
LuMind IDSC Presents the Collin Lis Humanitarian Award to Two Employees
In honor of Collin Lis, a kind and loving 11-year-old boy with Down syndrome, LuMind…
Shannon BergstresserJuly 11, 2024
FDA issues approval for new Alzheimer’s drug Kisunla; Down syndrome community is optimistic
FDA issues approval for Kisunla, new Alzheimer's drug; Down syndrome community optimistic On Tuesday, July…
Kate O’NeillJuly 3, 2024
Navigating the Road to Graduation for Students with Disabilities
Graduation from high school is a major accomplishment in the journey we each experience through…
Shannon BergstresserJune 12, 2024
